Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05414682
Other study ID # 148307
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date August 1, 2022
Est. completion date March 1, 2025

Study information

Verified date January 2024
Source University of Kansas Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The primary goal of this project is to evaluate feasibility and acceptability of the MIND+SOUL diet and its implementation. Secondary goals of this project are to evaluate cardiovascular risk profile, nutritional health status, and cognition in relation to the MIND+SOUL diet intervention.


Description:

This is a single arm trial designed to pilot test an adapted brain healthy diet intervention among older AA (n=30). Specifically, this study aims to evaluate the feasibility and acceptability of the brain healthy soul food diet intervention. As secondary outcomes, this study aims to assess body composition, cardiovascular risk, nutritional health status, and changes in cognition among older AA to form the basis of estimating power and sample size for a future full-scale randomized controlled clinical trial.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 30
Est. completion date March 1, 2025
Est. primary completion date July 1, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 55 Years and older
Eligibility Inclusion Criteria: - Identify as African American or Black - Age 55 and older - English Proficient - 1 or more of the following CVD risk factors (high blood pressure, high cholesterol, overweight/obesity with a BMI of 25 or more) - Cognitively Normal with an AD8 <2 (normal cognition) Exclusion Criteria: - No CVD risk factors - AD8 equal to or greater than 2 - Existing diet plan prescribed by a clinician - Non menopausal (because of DXA scan) - No internet connection - Uncontrolled hypertension, by history, or as indicated by supine systolic blood pressure >165 mmHg or diastolic blood pressure >95 mmHg at the baseline visit. If an initial blood pressure reading is higher than this, an additional attempt (at this visit or on another day) could be used before excluding a patient for uncontrolled hypertension - Neurological diseases that impact cognition - Other medical conditions likely to be negatively impacted by a diet change or that could confound the study data - Unable or unwilling to provide written consent - PI determination that study is unsafe or unsuitable - Active depression as determined by a score of 5 or above on the PHQ9 and deemed to be clinically significant by the medical monitor

Study Design


Intervention

Other:
MIND+SOUL Diet
The MIND+SOUL Diet is an adapted brain-healthy soul food diet.

Locations

Country Name City State
United States University of Kansas Health System Kansas City Kansas

Sponsors (1)

Lead Sponsor Collaborator
University of Kansas Medical Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Feasibility: Retention rate Feasibility will be assessed by retention rate. This will be calculated as the percentage of participants who complete all aspects of the intervention including cooking classes and coach directed dietary call support. 12 weeks
Secondary Body Composition Body composition will be measured using dual energy x-ray absorptiometry (DXA)5,6 , height, weight, and waist circumference. Using DXA we will specifically be focusing on changes in fat tissue from baseline to the 12-week mark of the MIND+SOUL intervention. Body composition will be collected at baseline and at the 12-week mark.
Secondary Cardiovascular risk profile Cardiovascular risk profile will be measured by 2 items; blood pressure and cholesterol. Blood pressure will be measured using the Omron 5 series blood pressure monitor. Cholesterol will be measured using the PTS Diagnostics Cardiocheck Plus Analyzer Cholesterol and Glucose Check. All cardiovascular risk prolife assessments will be collected at baseline and at the 12-week mark.
Secondary Nutritional Health Status : Nutritional health status change will be measured using the NHANES dietary screener questionnaire and the skin carotenoid assessment (Veggie Meter). Using the dietary screener questionnaire, we will specifically be focusing on changes in fruit and vegetable consumptions. Using the veggie meter, we will specifically be focusing on changes in skin carotenoid levels Nutritional health status change will be measured at baseline and at the 12-week mark
Secondary Cognitive Function Cognitive function will be measured using the NIH Toolbox to assess the following domains: memory, language, reading, vocabulary, processing speed, and executive function. Specifically the following tests will be administered: NIH-TB List Sorting Working Memory Test, NIH-TB Picture Vocabulary Test, NIH-TB Oral Reading Recognition Test, and the NIH-TB Pattern Comparison Processing Speed Test, and NIH-TB Flanker Inhibitory Control and Attention. For cognitive function we will be specifically focusing on changes in executive function. Cognitive function assessments be conducted at baseline and at the 12-week mark.
Secondary Feasibility: Reasons for Refusal Feasibility will be assessed by reasons for refusal to participate. Reasons for refusal to participate will be documented. Reasons for refusal to participate will be measured throughout the recruitment period which will last approximately three months.
Secondary Satisfaction - Visual analog scale Satisfaction with MIND+SOUL diet will be measured using a visual analog scale. The visual analog scale will be a score from 0, which indicates the least amount of satisfaction, to 10, which indicates the most amount of satisfaction. Satisfaction assessment will be conducted at the 12-week mark.
Secondary Acceptability Acceptability will be assessed using a REDCap online surveys. The acceptability survey will evaluate the affective attitude, burden, ethicality, perceived effectiveness, and self-efficacy of the intervention. Each question will be scored from 1 (strongly disagree) to 5 (strong agree) with the total survey score ranging from 20 to 100. Acceptability assessment will be conducted at the 12-week mark.
See also
  Status Clinical Trial Phase
Recruiting NCT05654272 - Development of CIRC Technologies
Recruiting NCT05650307 - CV Imaging of Metabolic Interventions
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT04056208 - Pistachios Blood Sugar Control, Heart and Gut Health Phase 2
Recruiting NCT04417387 - The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
Not yet recruiting NCT06211361 - Cardiac Rehabilitation Program in Patients With Cardiovascular Disease N/A
Not yet recruiting NCT06032572 - Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) N/A
Recruiting NCT04514445 - The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
Enrolling by invitation NCT04253054 - Chinese Multi-provincial Cohort Study-Beijing Project
Completed NCT03273972 - INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers N/A
Completed NCT03680638 - The Effect of Antioxidants on Skin Blood Flow During Local Heating Phase 1
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Completed NCT04083846 - Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed) Phase 1
Completed NCT04083872 - Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting) Phase 1
Completed NCT03693365 - Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
Completed NCT03466333 - Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia Phase 2
Completed NCT03619148 - The Incidence of Respiratory Symptoms Associated With the Use of HFNO N/A
Completed NCT04082585 - Total Health Improvement Program Research Project
Completed NCT05132998 - Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors N/A
Completed NCT05067114 - Solutions for Atrial Fibrillation Edvocacy (SAFE)